CLCM
Crawford Lake Capital Management Portfolio holdings
AUM
$32M
1-Year Return
12.29%
This Quarter Return
+12.3%
1 Year Return
+12.29%
3 Year Return
+171.37%
5 Year Return
+515.54%
10 Year Return
–
AUM
$263M
AUM Growth
+$52.9M
(+25%)
Cap. Flow
+$38M
Cap. Flow
% of AUM
14.45%
Top 10 Holdings %
Top 10 Hldgs %
51.57%
Holding
113
New
41
Increased
6
Reduced
8
Closed
31
Top Buys
| 1 |
Citigroup
C
|
+$14.7M |
| 2 |
NVIDIA
NVDA
|
+$11.4M |
| 3 |
Apple
AAPL
|
+$11M |
| 4 |
LOXO
Loxo Oncology, Inc
LOXO
|
+$10.4M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$8.54M |
Top Sells
| 1 |
Alibaba
BABA
|
+$14.6M |
| 2 |
Cleveland-Cliffs
CLF
|
+$13.9M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$10.1M |
| 4 |
Groupon
GRPN
|
+$7.03M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
+$6.77M |
Sector Composition
| 1 | Technology | 32.13% |
| 2 | Healthcare | 21.38% |
| 3 | Communication Services | 18.21% |
| 4 | Financials | 11.17% |
| 5 | Consumer Discretionary | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Best Buy
BBY
$16.5B
| $3.31M | 0.73% |
+57,773
| New | +$3.31M |
|
27
Herbalife
HLF
$964M
| $3.02M | 0.67% |
+84,678
| New | +$3.02M |
|
28
Aurinia Pharmaceuticals
AUPH
$1.68B
| $2.79M | 0.62% |
455,369
-163,031
| -26% | -$999K |
|
|
PTLA
29
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.66M | 0.59% |
+47,400
| New | +$2.66M |
|
30
Alphabet (Google) Class C
GOOG
$2.91T
| $2.54M | 0.56% |
+56,000
| New | +$2.54M |
|
|
AERI
31
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.51M | 0.56% |
+47,847
| New | +$2.51M |
|
32
Chegg
CHGG
$173M
| $2.31M | 0.51% |
+187,568
| New | +$2.31M |
|
33
Puma Biotechnology
PBYI
$227M
| $2.19M | 0.48% |
+25,000
| New | +$2.19M |
|
|
GRUB
34
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $2.16M | 0.48% |
+24,803
| New | +$2.16M |
|
35
Red Robin
RRGB
$122M
| $2.08M | 0.46% |
+31,933
| New | +$2.08M |
|
36
Tronox
TROX
$793M
| $2.06M | 0.45% |
135,919
-141,216
| -51% | -$2.14M |
|
37
AstraZeneca
AZN
$251B
| $2.05M | 0.45% |
+60,000
| New | +$2.05M |
|
38
PNC Financial Services
PNC
$79.8B
| $1.89M | 0.42% |
+15,147
| New | +$1.89M |
|
39
Sangamo Therapeutics
SGMO
$160M
| $1.64M | 0.36% |
+186,367
| New | +$1.64M |
|
40
Applied Optoelectronics
AAOI
$1.67B
| $1.55M | 0.34% |
+25,000
| New | +$1.55M |
|
41
Esperion Therapeutics
ESPR
$563M
| $1.5M | 0.33% |
32,295
-61,256
| -65% | -$2.84M |
|
|
GOOS
42
Canada Goose Holdings
GOOS
$1.42B
| $1.33M | 0.29% |
67,500
-169,038
| -71% | -$3.34M |
|
43
MetLife
MET
$53.4B
| $1.33M | 0.29% |
+27,152
| New | +$1.33M |
|
44
Thor Industries
THO
$5.83B
| $1.3M | 0.29% |
+12,400
| New | +$1.3M |
|
45
Okta
OKTA
$16.2B
| $1.23M | 0.27% |
+53,956
| New | +$1.23M |
|
|
CBIO
46
Crescent Biopharma, Inc. Common Stock
CBIO
$174M
| $1.22M | 0.27% |
+1,091
| New | +$1.22M |
|
47
Nike
NKE
$110B
| $1.19M | 0.26% |
+20,110
| New | +$1.19M |
|
48
Amazon
AMZN
$2.45T
| $1.16M | 0.26% |
+24,000
| New | +$1.16M |
|
|
BLUE
49
DELISTED
bluebird bio
BLUE
| $945K | 0.21% |
+695
| New | +$945K |
|
|
TRVG
50
trivago
TRVG
$231M
| $684K | 0.15% |
+5,780
| New | +$684K |
|